Cargando…

Rituximab Immunomonitoring Predicts Remission in Membranous Nephropathy

Primary membranous nephropathy (pMN) is an autoimmune kidney disease and a common cause of nephrotic syndrome in adults. Rituximab is becoming a first line therapy for patients with persistent nephrotic syndrome with proven safety and efficacy, achieving remission in 60%–80% of cases. For the remain...

Descripción completa

Detalles Bibliográficos
Autores principales:	Teisseyre, Maxime, Cremoni, Marion, Boyer-Suavet, Sonia, Crepin, Thomas, Benzaken, Sylvia, Zorzi, Kévin, Esnault, Vincent, Brglez, Vesna, Seitz-Polski, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548826/ https://www.ncbi.nlm.nih.gov/pubmed/34721403 http://dx.doi.org/10.3389/fimmu.2021.738788

Ejemplares similares

Analysis and Management of Rituximab Resistance in PLA2R1-Associated Membranous Nephropathy
por: Teisseyre, Maxime, et al.
Publicado: (2021)

Advances in the Management of Primary Membranous Nephropathy and Rituximab-Refractory Membranous Nephropathy
por: Teisseyre, Maxime, et al.
Publicado: (2022)

Neutralizing Anti-Rituximab Antibodies and Relapse in Membranous Nephropathy Treated With Rituximab
por: Boyer-Suavet, Sonia, et al.
Publicado: (2020)

Th17-Immune Response in Patients With Membranous Nephropathy Is Associated With Thrombosis and Relapses
por: Cremoni, Marion, et al.
Publicado: (2020)

Humoral and Cellular Response of Frontline Health Care Workers Infected by SARS-CoV-2 in Nice, France: A Prospective Single-Center Cohort Study
por: Cremoni, Marion, et al.
Publicado: (2021)

Personalized Medicine for PLA2R1-Related Membranous Nephropathy: A Multicenter Randomized Control Trial
por: Brglez, Vesna, et al.
Publicado: (2020)

Complement Pathways in Membranous Nephropathy: Complex and Multifactorial
por: Brglez, Vesna, et al.
Publicado: (2020)

Both Humoral and Cellular Immune Responses to SARS-CoV-2 Are Essential to Prevent Infection: a Prospective Study in a Working Vaccinated Population from Southern France
por: Graça, Daisy, et al.
Publicado: (2023)

Low baseline IFN-γ response could predict hospitalization in COVID-19 patients
por: Cremoni, Marion, et al.
Publicado: (2022)

Functional Exhaustion of Type I and II Interferons Production in Severe COVID-19 Patients
por: Ruetsch, Caroline, et al.
Publicado: (2021)

Air pollution exposure induces a decrease in type II interferon response: A paired cohort study
por: Allouche, Jonathan, et al.
Publicado: (2022)

Breakthrough infections due to SARS-CoV-2 Delta variant: relation to humoral and cellular vaccine responses
por: Buscot, Matthieu, et al.
Publicado: (2023)

Anti-PLA2R1 Antibodies Containing Sera Induce In Vitro Cytotoxicity Mediated by Complement Activation
por: Lateb, Maël, et al.
Publicado: (2019)

Baseline and early functional immune response is associated with subsequent clinical outcomes of PD-1 inhibition therapy in metastatic melanoma patients
por: Gérard, Alexandre, et al.
Publicado: (2021)

Proteinuria as a Biomarker for COVID-19 Severity
por: Ouahmi, Hajar, et al.
Publicado: (2021)

Impact of Isolation Time of COVID-19 Patients in Intensive Care Unit on Healthcare Workers Contamination and Nursing Care Intensity
por: Doyen, Denis, et al.
Publicado: (2022)

Only Follow-Up of Memory B Cells Helps Monitor Rituximab Administration to Patients with Neuromyelitis Optica Spectrum Disorders
por: Lebrun, Christine, et al.
Publicado: (2018)

Development of the automated immunomonitoring system
por: Osawa, Ryuji, et al.
Publicado: (2014)

From Immunomonitoring to Immune Intervention
por: Toubert, Antoine, et al.
Publicado: (2015)

Membranous Nephropathy After Exposure to Immune Checkpoint Inhibitors
por: Benyahia, Rayane, et al.
Publicado: (2023)

Humoral and cellular responses after a third dose of SARS-CoV-2 BNT162b2 vaccine in patients with lymphoid malignancies
por: Re, Daniel, et al.
Publicado: (2022)

TNF Blocking Therapies and Immunomonitoring in Patients with Inflammatory Bowel Disease
por: Altwegg, Romain, et al.
Publicado: (2014)

Longitudinal immunomonitoring following Tocilizumab in rheumatoid arthritis
por: Pers, Yves-Marie, et al.
Publicado: (2011)

Strategies for Immunomonitoring after Vaccination and during Infection
por: Adam, Lucille, et al.
Publicado: (2021)

Remission of Refractory Membranous Nephropathy by Low-dose Rituximab: A Case Report
por: Wang, Xiao-Pei, et al.
Publicado: (2016)

Anti-phospholipase A2 receptor antibody levels at diagnosis predicts spontaneous remission of idiopathic membranous nephropathy
por: Jullien, Perrine, et al.
Publicado: (2017)

In vitro immunomonitoring of insect venom-allergic patients on immunotherapy
por: Cifuentes, Liliana, et al.
Publicado: (2014)

Clinical impact of immunomonitoring in the treatment of inflammatory bowel disease
por: Tighe, Donal, et al.
Publicado: (2017)

Immunomonitoring of Human Breast Milk Cells During HCMV-Reactivation
por: Lazar, Katrin, et al.
Publicado: (2021)

Kappa Free Light Chains, Soluble Interleukin-2 Receptor, and Interleukin-6 Help Explore Patients Presenting With Brain White Matter Hyperintensities
por: Levraut, Michael, et al.
Publicado: (2022)

Rituximab in Membranous Nephropathy
por: Gauckler, Philipp, et al.
Publicado: (2021)

Lipofection with Synthetic mRNA as a Simple Method for T-Cell Immunomonitoring
por: Jarzebska, Natalia Teresa, et al.
Publicado: (2021)

Membranous nephropathy with systemic light-chain amyloidosis of remission after rituximab therapy: A case report
por: Zhang, Jiao, et al.
Publicado: (2023)

Immune response to BNT162b2 SARS-CoV-2 vaccine in patients living with HIV: The COVIH-DAPT study
por: Manni, Sabrina, et al.
Publicado: (2023)

Systems-Level Immunomonitoring from Acute to Recovery Phase of Severe COVID-19
por: Rodriguez, Lucie, et al.
Publicado: (2020)

Untargeted plasma metabolomic fingerprinting highlights several biomarkers for the diagnosis and prognosis of coronavirus disease 19
por: Occelli, Céline, et al.
Publicado: (2022)

Identification of new MUC1 epitopes using HLA-transgenic animals: implication for immunomonitoring
por: Scheikl-Gatard, Tanja, et al.
Publicado: (2017)

Multicentre Harmonisation of a Six-Colour Flow Cytometry Panel for Naïve/Memory T Cell Immunomonitoring
por: Macchia, Iole, et al.
Publicado: (2020)

Immunomonitoring of Monocyte and Neutrophil Function in Critically Ill Patients: From Sepsis and/or Trauma to COVID-19
por: Udovicic, Ivo, et al.
Publicado: (2021)

Treatment with rituximab in idiopathic membranous nephropathy
por: Fiorentino, Marco, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_v0sh660fm67in8dcskk0f8e172